NO944946D0 - Forgrenet-amino-substituerte tiazoler, fremgangsmåter for fremstilling av dem og farmasöytiske blandinger inneholdende dem - Google Patents
Forgrenet-amino-substituerte tiazoler, fremgangsmåter for fremstilling av dem og farmasöytiske blandinger inneholdende demInfo
- Publication number
- NO944946D0 NO944946D0 NO944946A NO944946A NO944946D0 NO 944946 D0 NO944946 D0 NO 944946D0 NO 944946 A NO944946 A NO 944946A NO 944946 A NO944946 A NO 944946A NO 944946 D0 NO944946 D0 NO 944946D0
- Authority
- NO
- Norway
- Prior art keywords
- branched
- amino
- processes
- preparation
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Cardiology (AREA)
- Transplantation (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9315386A FR2714059B1 (fr) | 1993-12-21 | 1993-12-21 | Dérivés amino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent. |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO944946D0 true NO944946D0 (no) | 1994-12-20 |
| NO944946L NO944946L (no) | 1995-06-22 |
| NO304598B1 NO304598B1 (no) | 1999-01-18 |
Family
ID=9454174
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO944946A NO304598B1 (no) | 1993-12-21 | 1994-12-20 | Forgrenet-amino-substituerte tiazoler, anvendelse av dem og farmas°ytiske blandinger inneholdende dem |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US5602132A (no) |
| EP (1) | EP0659747B1 (no) |
| JP (1) | JP3022223B2 (no) |
| KR (1) | KR950017980A (no) |
| CN (1) | CN1058964C (no) |
| AT (1) | ATE164578T1 (no) |
| AU (1) | AU685876B2 (no) |
| CA (1) | CA2138638A1 (no) |
| CZ (1) | CZ323094A3 (no) |
| DE (1) | DE69409337T2 (no) |
| DK (1) | DK0659747T3 (no) |
| ES (1) | ES2115904T3 (no) |
| FI (1) | FI945975A (no) |
| FR (1) | FR2714059B1 (no) |
| HU (1) | HUT71103A (no) |
| IL (1) | IL112074A (no) |
| NO (1) | NO304598B1 (no) |
| NZ (1) | NZ270229A (no) |
| PL (1) | PL306402A1 (no) |
| RU (1) | RU2107063C1 (no) |
| SI (1) | SI0659747T1 (no) |
| TW (1) | TW401410B (no) |
| ZA (1) | ZA9410196B (no) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5795905A (en) * | 1995-06-06 | 1998-08-18 | Neurocrine Biosciences, Inc. | CRF receptor antagonists and methods relating thereto |
| FR2754258B1 (fr) | 1996-10-08 | 1998-12-31 | Sanofi Sa | Derives d'aminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant |
| FR2796380B3 (fr) * | 1999-07-15 | 2001-08-17 | Sanofi Synthelabo | Nouveaux derives d'aminothiazoles, leur preparation et les compositions pharmaceutiques les contenant |
| TWI271406B (en) | 1999-12-13 | 2007-01-21 | Eisai Co Ltd | Tricyclic condensed heterocyclic compounds, preparation method of the same and pharmaceuticals comprising the same |
| CA2398956A1 (en) * | 2000-02-14 | 2001-08-16 | Japan Tobacco Inc. | A pharmaceutical composition for prophylaxis or therapy of a postoperative stress |
| EP1149583A3 (en) * | 2000-04-13 | 2001-11-14 | Pfizer Products Inc. | Combinations of corticotropin releasing factor antagonists and growth hormone secretagogues |
| US6515005B2 (en) * | 2000-09-21 | 2003-02-04 | Bristol-Myers Squibb Company | Substituted azole derivatives as inhibitors of corticotropin releasing factor |
| TWI312347B (en) | 2001-02-08 | 2009-07-21 | Eisai R&D Man Co Ltd | Bicyclic nitrogen-containing condensed ring compounds |
| WO2002083863A2 (en) | 2001-04-17 | 2002-10-24 | Sepracor, Inc. | Thiazole and other heterocyclic ligands and use thereof |
| CA2443802C (en) | 2001-04-27 | 2010-04-13 | Eisai Co., Ltd. | Pyrazolo[1,5-a]pyridines and medicines containing the same |
| EP1423113A4 (en) * | 2001-08-13 | 2007-04-18 | Phenex Pharmaceuticals Ag | NR1H4 NUCLEAR RECEPTOR BINDING COMPOUNDS |
| ATE381542T1 (de) * | 2001-08-13 | 2008-01-15 | Phenex Pharmaceuticals Ag | Nr1h4-kern-rezeptor-bindende verbindungen |
| AU2003239869A1 (en) * | 2002-05-23 | 2003-12-12 | Michael Holick | Use of a parathyroid hormone peptide analogs for the treatment of vaginal atrophy |
| US7176216B2 (en) | 2002-10-22 | 2007-02-13 | Eisai Co., Ltd. | 7-phenylpyrazolopyridine compounds |
| EP1555265B1 (en) | 2002-10-22 | 2009-03-25 | Eisai R&D Management Co., Ltd. | 7-phenyl pyrazolopyridine compounds |
| CA2721670C (en) | 2008-04-15 | 2013-09-10 | Eisai R&D Management Co., Ltd. | 3-phenylpyrazolo[5,1-b]thiazole compound |
| AR078521A1 (es) | 2009-10-08 | 2011-11-16 | Eisai R&D Man Co Ltd | Compuesto pirazolotiazol |
| JPWO2011043387A1 (ja) * | 2009-10-08 | 2013-03-04 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ピラゾロオキサゾール化合物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3299087A (en) * | 1961-04-24 | 1967-01-17 | Geigy Chem Corp | Nu, nu'-bis-(thiazolyl)-phenylenediamines |
| US5232921A (en) * | 1987-03-12 | 1993-08-03 | Sanofi | Thiazole derivatives active on the cholinergic system, process for obtention and pharmaceutical compositions |
| FR2612187B1 (fr) * | 1987-03-12 | 1989-07-21 | Sanofi Sa | Derives du thiazole actifs sur le systeme cholinergique, leur procede de preparation et compositions pharmaceutiques en contenant |
| DE3923675A1 (de) * | 1989-07-18 | 1991-01-24 | Basf Ag | Amonoalkylsubstituierte 2-aminothiazole und diese enthaltende therapeutische mittel |
| FR2656610B1 (fr) * | 1989-12-29 | 1992-05-07 | Sanofi Sa | Derives d'amino-2 phenyl-4 thiazole, leur procede de preparation et leur application therapeutique. |
| FR2692893B1 (fr) * | 1992-06-24 | 1994-09-02 | Sanofi Elf | Dérivés alkylamino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent. |
-
1993
- 1993-12-21 FR FR9315386A patent/FR2714059B1/fr not_active Expired - Fee Related
-
1994
- 1994-12-19 TW TW083111880A patent/TW401410B/zh active
- 1994-12-19 CZ CZ943230A patent/CZ323094A3/cs unknown
- 1994-12-20 DK DK94402954T patent/DK0659747T3/da active
- 1994-12-20 NO NO944946A patent/NO304598B1/no not_active IP Right Cessation
- 1994-12-20 CA CA002138638A patent/CA2138638A1/en not_active Abandoned
- 1994-12-20 AT AT94402954T patent/ATE164578T1/de active
- 1994-12-20 HU HU9403690A patent/HUT71103A/hu unknown
- 1994-12-20 DE DE69409337T patent/DE69409337T2/de not_active Expired - Fee Related
- 1994-12-20 FI FI945975A patent/FI945975A/fi unknown
- 1994-12-20 AU AU81632/94A patent/AU685876B2/en not_active Ceased
- 1994-12-20 SI SI9430138T patent/SI0659747T1/xx unknown
- 1994-12-20 IL IL11207494A patent/IL112074A/en not_active IP Right Cessation
- 1994-12-20 ES ES94402954T patent/ES2115904T3/es not_active Expired - Lifetime
- 1994-12-20 EP EP94402954A patent/EP0659747B1/fr not_active Expired - Lifetime
- 1994-12-20 JP JP6316765A patent/JP3022223B2/ja not_active Expired - Lifetime
- 1994-12-20 PL PL94306402A patent/PL306402A1/xx unknown
- 1994-12-20 RU RU94044534A patent/RU2107063C1/ru active
- 1994-12-21 ZA ZA9410196A patent/ZA9410196B/xx unknown
- 1994-12-21 KR KR1019940035536A patent/KR950017980A/ko active IP Right Grant
- 1994-12-21 NZ NZ270229A patent/NZ270229A/en unknown
- 1994-12-21 CN CN94119558A patent/CN1058964C/zh not_active Expired - Fee Related
- 1994-12-21 US US08/360,351 patent/US5602132A/en not_active Expired - Fee Related
-
1996
- 1996-11-27 US US08/756,402 patent/US5821255A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU685876B2 (en) | 1998-01-29 |
| NZ270229A (en) | 1996-04-26 |
| IL112074A (en) | 1998-12-06 |
| HUT71103A (en) | 1995-11-28 |
| JPH07224051A (ja) | 1995-08-22 |
| CN1127252A (zh) | 1996-07-24 |
| ES2115904T3 (es) | 1998-07-01 |
| EP0659747A1 (fr) | 1995-06-28 |
| RU94044534A (ru) | 1996-10-27 |
| DE69409337D1 (de) | 1998-05-07 |
| CZ323094A3 (en) | 1995-07-12 |
| AU8163294A (en) | 1995-06-29 |
| FR2714059A1 (fr) | 1995-06-23 |
| DE69409337T2 (de) | 1998-10-08 |
| FR2714059B1 (fr) | 1996-03-08 |
| TW401410B (en) | 2000-08-11 |
| NO944946L (no) | 1995-06-22 |
| NO304598B1 (no) | 1999-01-18 |
| EP0659747B1 (fr) | 1998-04-01 |
| ZA9410196B (en) | 1996-06-21 |
| KR950017980A (ko) | 1995-07-22 |
| PL306402A1 (en) | 1995-06-26 |
| ATE164578T1 (de) | 1998-04-15 |
| FI945975A0 (fi) | 1994-12-20 |
| SI0659747T1 (en) | 1998-08-31 |
| CN1058964C (zh) | 2000-11-29 |
| DK0659747T3 (da) | 1999-01-11 |
| HU9403690D0 (en) | 1995-02-28 |
| CA2138638A1 (en) | 1995-06-22 |
| FI945975A (fi) | 1995-06-22 |
| IL112074A0 (en) | 1995-03-15 |
| JP3022223B2 (ja) | 2000-03-15 |
| US5602132A (en) | 1997-02-11 |
| US5821255A (en) | 1998-10-13 |
| RU2107063C1 (ru) | 1998-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO944946D0 (no) | Forgrenet-amino-substituerte tiazoler, fremgangsmåter for fremstilling av dem og farmasöytiske blandinger inneholdende dem | |
| IL123002A0 (en) | 1-Phenyl-2- phenylacetoxy- ethanone derivatives | |
| DK0468012T3 (da) | 17beta-substituerede 4-aza-5alfa-androstan-3-on-derivater og fremgangsmåde til fremstilling deraf | |
| LU91145I9 (no) | ||
| HUT68963A (en) | Novel 4-arylpiperazines and 4-arylpiperidines, pharmaceutical compositions comprising them and the proces for producing thereof | |
| DK0513543T3 (da) | Amidinophenylalaninderivater, fremgangsmåde til deres fremstilling, deres anvendelse og antikoagulationsmidler med indehold deraf | |
| FI913478A0 (fi) | Diazinderivat. | |
| ES2162934T3 (es) | Derivados de fenil xantina. | |
| DK0618209T3 (da) | Pyridothiadiaziner, fremgangsmåder til fremstilling heraf og farmaceutiske sammensætninger indeholdende dem | |
| ME00106B (me) | Derivati aminoalkenilbenzoil-benzofurana ili benzotiopena, postupak za njihovo pripremanje i kompozicije koje ih sadrže | |
| EA200100516A1 (ru) | Производные 3,3-биарилпиперидина и 2,2-биарилморфолина | |
| ATE66230T1 (de) | Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel. | |
| PL328225A1 (en) | Diphenylstilbenes as pro-medications used to produce cox-2-inhibitors | |
| DK259589D0 (da) | Joderede, ikke-ioniske trijodbenzenforbindelser og kontrastmiddel indeholdende dem | |
| ATE100463T1 (de) | Renin-hemmende aminooligohydroxy-derivate. | |
| ZA941196B (en) | Angiopeptin cyclopeptide compounds process for the preparation thereof and pharmaceutical compositions containing them | |
| IL87197A0 (en) | Leukotriene antagonists,precursors of same,processes for the preparation thereof and pharmaceutical compositions containing same | |
| SE9203824D0 (sv) | Benzofuranylimidazole derivatives a process for the preparation and therapeutical compositions containing the same | |
| RU92016209A (ru) | Бензофуранилимидазольные производные, способ их получения и терапевтические композиции, содержащие названные производные | |
| DK0635491T3 (da) | (Thia)cycloalkylab indoler, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse forbindelser. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN JUNE 2001 |